BMAC – Biopharmaceutical Manufacturer's Advisory Council
An initiative by leading Biopharmaceutical companies in the world to establish Singapore as the country of choice for global biomedical sciences manufacturing.
Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Minoru Tanaka) will manufacture and supply intermediates to Shionogi & Co., Ltd. (Headquarters: Chuo-ku,Osaka; Chief Executive Officer: Isao Teshirogi, Ph.D.) for use in Xocova®*1 (EnsitrelvirFumaric Acid) Tablets 125mg, a drug for the treatment of SARS-Cov-2 infection.
Kaneka Corporation (Headquarters: Minato-ku, Tokyo; President: Minoru Tanaka) has received authorization for the manufacture and sale of “Kaneka Immunochromatography SARS-CoV-2 Ag,” a COVID-19 antigen test kit, and launched the new in-vitro diagnostic agent on June 15. The kit has a suggested retail price of 13,200 yen (for 10 tests), including tax.
Test kit capable of detecting both types of Omicron variants with a single PCR test